Comments
Loading...
Chemomab Therapeutics (NASDAQ:CMMB) Stock, Earnings Estimates, EPS, And Revenue
Chemomab Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 6
EPS Estimate
$-0.010
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Chemomab Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Chemomab Therapeutics (CMMB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.20 | $-0.01 | -1900.0 % |
| Q3 | 2023-11-09 | $-0.34 | $-0.02 | -1600.0 % |
| Q2 | 2023-08-14 | $-0.72 | $-0.80 | 10.0 % |
| Q1 | 2023-05-11 | $-0.80 | $-0.03 | -2566.7 % |
Chemomab Therapeutics (CMMB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?
Chemomab Therapeutics (CMMB) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Chemomab Therapeutics (NASDAQ:CMMB)?
The Actual EPS was $-0.20, which missed the estimate of $-0.01.
What were Chemomab Therapeutics’s (NASDAQ:CMMB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.